Asit Parikh, Director at Phathom Pharmaceuticals, Inc. (PHAT), bought 10,000 shares at $2.60 ($25K) on 2025-05-06, disclosed to the SEC on 2025-05-08.
Seasonal purchase ($25k) by Director — this insider has traded PHAT in May in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.60 | 5,000 | $13K | 52.0% |
| 2 | $2.40 | 5,000 | $12K | 48.0% |
| Total | $2.50 avg | 10,000 | $25K | 100% |
| Filing → |
| PHAT | BUY | 2023-11-08 | $59K | — | Filing → |
| PHAT | BUY | 2023-04-11 | $8K | — | Filing → |
| PHAT | BUY | 2023-02-14 | $39K | — | Filing → |